Abstract:Background: SARS-CoV-2, the virus responsible for COVID-19, causes widespread damage in the lungs in the setting of an overzealous immune response whose origin remains unclear. Methods: We present a scalable, propagable, personalized, cost-effective adult stem cell-derived human lung organoid model that is complete with both proximal and distal airway epithelia. Monolayers derived from adult lung organoids (ALOs), primary airway cells, or hiPSC-derived alveolar type II (AT2) pneumocytes were infected with SARS-CoV-2 to create in vitro lung models of COVID-19. Results: Infected ALO monolayers best recapitulated the transcriptomic signatures in diverse cohorts of COVID-19 patient-derived respiratory samples. The airway (proximal) cells were critical for sustained viral infection, whereas distal alveolar differentiation (AT2→AT1) was critical for mounting the overzealous host immune response in fatal disease; ALO monolayers with well-mixed proximodistal airway components recapitulated both. Conclusions: Findings validate a human lung model of COVID-19, which can be immediately utilized to investigate COVID-19 pathogenesis and vet new therapies and vaccines. Funding: This work was supported by the National Institutes for Health (NIH) grants 1R01DK107585-01A1, 3R01DK107585-05S1 (to SD); R01-AI141630, CA100768 and CA160911 (to PG) and R01-AI 155696 (to PG, DS and SD); R00-CA151673 and R01-GM138385 (to DS), R01- HL32225 (to PT), UCOP-R00RG2642 (to SD and PG), UCOP-R01RG3780 (to P.G. and D.S) and a pilot award from the Sanford Stem Cell Clinical Center at UC San Diego Health (P.G, S.D, D.S). GDK was supported through The American Association of Immunologists Intersect Fellowship Program for Computational Scientists and Immunologists. L.C.A's salary was supported in part by the VA San Diego Healthcare System. This manuscript includes data generated at the UC San Diego Institute of Genomic Medicine (IGC) using an Illumina NovaSeq 6000 that was purchased with funding from a National Institutes of Health SIG grant (#S10 OD026929).

Design, infectability, and transcriptomic analysis of transregionally differentiated and scalable lung organoids derived from adult bronchial cells.

A distal lung organoid model to study interstitial lung disease, viral infection and human lung development

Human lung organoid: Models for respiratory biology and diseases

Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19

Progenitor identification and SARS-CoV-2 infection in human distal lung organoids

Advanced lung organoids for respiratory system and pulmonary disease modeling

Lung Organoids—The Ultimate Tool to Dissect Pulmonary Diseases?

Open questions in human lung organoid research

Isolation, Culture, and Phenotypic Analysis of Murine Lung Organoids

Generation of Complete Multi−Cell Type Lung Organoids From Human Embryonic and Patient‐Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation

Human Lung Organoids—A Novel Experimental and Precision Medicine Approach

Lung organoids: current uses and future promise

Organoid modeling of human fetal lung alveolar development reveals mechanisms of cell fate patterning and neonatal respiratory disease

Organogenesis of adult lung in a dish: Differentiation, disease and therapy

Organoids As a Powerful Model for Respiratory Diseases

Alveolar Organoids in Lung Disease Modeling

Long-term expanding human airway organoids for disease modeling

Recent advances in lung organoid development and applications in disease modeling

Lung Organoids and Their Use To Study Cell-Cell Interaction

Lamination-based Organoid Spatially Resolved Transcriptomics Technique for Primary Lung and Liver Organoid Characterization.

Development and Functional Characterization of Fetal Lung Organoids